MedPharm, a specialist pharmaceutical development company, recognised internationally for its expertise in topical drug delivery systems and Molecular Profiles, a leading specialist contract development and clinical trial manufacturing organisation, announced that they have formed a strategic alliance. The new alliance branded as MPGMP, provides an enhanced service for the manufacture of topical formulation clinical trial material.
Both companies share a record of successfully handling challenging compounds; something that is critical for topical formulations which often require small batch dosage forms and complicated compound analysis. Together, Molecular Profiles and MedPharm can work on the manufacture of a range of pharmaceutical products including more complex new chemical entities (NCEs), manufacturing clinical trial supplies at relatively small batch sizes to get to proof of concept in clinical trials (Phase 2) as early as possible.
Andrew Muddle, CEO at MedPharm Ltd comments: “We are pleased to announce our strategic alliance in GMP clinical trial supplies with Molecular Profiles and look forward to offering a seamless end-to-end topical formulation development service to our clients. MedPharm’s aim is to continue to build on its reputation as a specialist topical pharmaceutical company concentrating on the development of products for dermatology and other topical indications. Our partnership with Molecular Profiles will help us to drive this aim forward, offering strengthened expertise and an expanded range of GMP services enabling the provision of clinical trial services to our clients.”
Nikin Patel, CEO at Molecular Profiles adds: “The alliance with MedPharm, is an opportunity for both companies to expand our service offerings within topical drug delivery. Under our expansion program, we remain committed to providing our clients with access to the best innovation and manufacturing expertise. We are confident that together we can deliver a high end service.”
Date: August 20, 2012
Source: Molecular Profiles
Filed Under: Drug Discovery
